| Authors: |
Quinlan L; Blood Cancer Program, Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia.; Adelaide University, Adelaide, SA, Australia., Yeung D; Blood Cancer Program, Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia.; Adelaide University, Adelaide, SA, Australia.; Royal Adelaide Hospital, Adelaide, SA, Australia.; Australasian Leukaemia and Lymphoma Group (ALLG), Melbourne, VIC, Australia., Heatley S; Adelaide University, Adelaide, SA, Australia., White D; Blood Cancer Program, Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia.; Adelaide University, Adelaide, SA, Australia.; Australasian Leukaemia and Lymphoma Group (ALLG), Melbourne, VIC, Australia.; Australian and New Zealand Children's Haematology Oncology Group (ANZCHOG), Clayton, VIC, Australia., Page E; Blood Cancer Program, Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, Australia. elyse.page@sahmri.com.; Adelaide University, Adelaide, SA, Australia. elyse.page@sahmri.com. |